Reaction Details Report a problem with these data
Target
Platelet-activating factor receptor
Ligand
BDBM50011869
Substrate
n/a
Meas. Tech.
ChEBML_154999
IC50
650±n/a nM
Citation
 Walser, A; Flynn, T; Mason, C; Crowley, H; Maresca, C; O'Donnell, M Thienotriazolodiazepines as platelet-activating factor antagonists. Steric limitations for the substituent in position 2. J Med Chem 34:1440-6 (1991) [PubMed]  Article 
Target
Name:
Platelet-activating factor receptor
Synonyms:
PAF Platelet activating factor | PAF-R | PAFR | PTAFR | PTAFR_HUMAN | Platelet activating factor receptor | Platelet-activating factor receptor
Type:
Enzyme Catalytic Domain
Mol. Mass.:
39219.60
Organism:
Homo sapiens (Human)
Description:
PAF Platelet activating factor PTAFR HUMAN::P25105
Residue:
342
Sequence:
MEPHDSSHMDSEFRYTLFPIVYSIIFVLGVIANGYVLWVFARLYPCKKFNEIKIFMVNLTMADMLFLITLPLWIVYYQNQGNWILPKFLCNVAGCLFFINTYCSVAFLGVITYNRFQAVTRPIKTAQANTRKRGISLSLVIWVAIVGAASYFLILDSTNTVPDSAGSGNVTRCFEHYEKGSVPVLIIHIFIVFSFFLVFLIILFCNLVIIRTLLMQPVQQQRNAEVKRRALWMVCTVLAVFIICFVPHHVVQLPWTLAELGFQDSKFHQAINDAHQVTLCLLSTNCVLDPVIYCFLTKKFRKHLTEKFYSMRSSRKCSRATTDTVTEVVVPFNQIPGNSLKN
  
Inhibitor
Name:
BDBM50011869
Synonyms:
2-(4-Butyl-phenylethynyl)-4-(2-chloro-phenyl)-9-methyl-6H-1-thia-5,7,8,9a-tetraaza-cyclopenta[e]azulene | CHEMBL32767
Type:
Small organic molecule
Emp. Form.:
C27H23ClN4S
Mol. Mass.:
471.016
SMILES:
CCCCc1ccc(cc1)C#Cc1cc2c(s1)-n1c(C)nnc1CN=C2c1ccccc1Cl |c:27|
Structure:
Search PDB for entries with ligand similarity: